Google Custom Search

Index of All HIV and AIDS Articles by Topic ( A to Z)
 

A
Abacavir Sensitivity Reaction
About Us
Adverse Events
Adherence
Agenerase (amprenavir)
AIDS-related Non-Hodgkin's Lymphoma
Anemia / Fatigue
Aplaviroc
Aptivus (Tipranavir)
Atripla (efavirenz + emtricitabine + tenofovir)

Sub Topics for Main Sections

AIDS-defining Illnesses
Experimental Drugs
Fat Redistribution
FDA-Approved Treatments
HIV and HIV-Drug Related Adverse Events
Lipodystrophy / Morphologic Changes
Metabolic Complications
Opportunistic Infections (OIs)
Reports from Research Meetings
Tests
PDF Formatted Reports / Guides

 

 

HIV and HIV-Drug Related Adverse Events
Adverse Events
Anemia / Fatigue
Antidepressants
Bone Disorders
Central Nervous System (CNS)
Cerebrospinal Fluid (CSF)
Dementia
Depression
Diarrhea / GI Symptoms

Hepatotoxicity (Liver Toxicity)
Lactic Acidosis/Hyperlactatemia
Mitochondrial Toxicity
Mitochondrial DNA (mtDNA)
Myalgias (muscle aches)
Neurotoxicity   
Pancreatitis
Peripheral Neuropathy
Post-traumatic Stress Disorder (PTSD)
Psychiatric (mental) Disorders
Renal (Kidney) Toxicity / Failure


AIDS-defining Illnesses
Presence of any of these conditions accompanied
by HIV infection renders them an AIDS-defining illness.
AIDS-related Non-Hodgkin's Lymphoma
CMV Retinitis
Cryptococcal Meningitis
Cryptosporidiosis
Cytomegalovirus disease
Esophageal candidiasis
Histoplasmosis
HIV-related dementia
HIV Wasting syndrome
Kaposi sarcoma
Mycobacterium avium complex (MAC)
Pneumocystis carinii pneumonia (PCP)
Progressive Multifocal Leukoencephalopathy (PML)
Toxoplasmosis
Tuberculosis

Lipodystrophy / Morphologic Changes
(body shape changes)
Fat Loss (lipoatrophy)
Fat Accumulation (lipotrophy)
Buffalo Hump (BH)
Cardiovascular Disease
Cosmetic Procedures
Facial Implants
Growth Hormone
HIV Wasting
Hormone Therapies


Fat Redistribution
Fat Loss (lipoatrophy)
Fat Accumulation (lipotrophy)

Metabolic Complications
Cardiovascular Disease
Cholesterol / Triglycerides
Diabetes
Dyslipidemias
Glucose MetabolismInsulin Resistance
Gynecomastia
Hyperlactatemia
Hyperlipidemia
Myocardial Infarction (MI)

Opportunistic Infections (OIs)
Candidiasis
CMV Retinitis
Cryptococcal Meningitis
Humanpapillomavirus (HPV)
Mycobacterium avium Complex
Pneumocystis carinii pneumonia (PCP)
Progressive Multifocal Leukoencephalopathy (PML)
Pneumonia
Tuberculosis



Tests
Genotype Resistance Testing
Phenotype Resistance Testing
HIV RNA and HIV bDNA Testing

Resistance Testing

Concentration-controlled Intervention (CCI)

CD4 T Cell Count/ Percent

 

 

 

 

B
Boosted Protease Inhibitors
C
Candidiasis
Cancers and Malignancies
Cardiovascular Disease

CCR5 / CCR4 Antagonist Inhibitors
CD4 T Cell Count/ Percent
Cholesterol / Triglycerides
Children and Infants
Central Nervous System (CNS)
Clinical Trials
CME Programs
CMV Retinitis

Combivir (AZT plus 3TC)
Crixivan (indinavir)
D
Depression
Diabetes
Doctor Is In
Drug Abuse
Drug Interactions
Drug Resistance Testing
Dyslipidemias
E
Emtriva (emtricitabine; FTC)
Entry (Fusion) Inhibitors
Epivir (lamivudine; 3TC)
Epzicom (abacavir + lamivudine)
Experimental Anti-HIV Drugs
F
Facial Implants
Fat Loss (lipoatrophy)
Fat Accumulation (lipotrophy)
Fat Redistribution
FDA-approved Treatments
Fixed-dose Combinations (FDC)
Fortovase (saquinavir soft gel capsules)
Fuzeon (enfuvirtide; T-20)
G
Genotypic Resistance Testing
Glucose MetabolismInsulin Resistance
Growth Factors
Guidelines
I
Immune Restoration
Immune Reconstitution Disease (IRD)
Immune Reconstitution Inflammatory Syndrome (IRIS)
Insulin Resistance
Invirase (saquinavir hard gel capsules)
K
Kaletra (lopinavir/ritronavir)
Kaposi's Sarcoma
Kidney Toxicity / Kidney Failure
L
Lactic Acidosis/Hyperlactatemia
Lexiva (Fosamprenavir)
Lipoatrophy (fat loss)
Lipotrophy (fat accumulation)
Liver Transplantation
M
Malignancies and Cancers
Men Who Have Sex with Men (MSM)
Mortality and Morbidity
Mother-to-Child Transmission
Mycobacterium avium Complex (MAC)
Myocardial Infarction (MI)
N
Neuropathy
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Nucleotide Reverse Transcriptase Inhibitors (NtRTIs)
O
Opportunistic Infections (OIs)
P
Pharmacokinetics
Pneumonia
Pneumocystis carinii pneumonia (PCP)
Phenotypic Resistance Testing
Post-eExposure Prophylaxis (PEP)

Pregnancy
Prevention (HIV)
Prezista (darunavir)
Protease Inhibitors (PIs) / Boosted PIs
R
Rescriptor (delavirdine)
Research Conference Coverage
Resistance
Resistance Testing
Retrovir (zidovudine; AZT)
Reyataz (atazanavir)
S
Sexually Transmitted Diseases (STD)
Substance Abuse
Sustiva (efavirenz)
T
Transplantation
Treatment Failure
Treatment Interruptions (TIs)
Trizivir  Fixed-dose Combination (abacavir plus zidovudine plus lamivudine)
Truvada  Fixed-dose Combination  (Tenofovir / Emtricitabine)
Tuberculosis
V
Vaccines
Videx (didanosine; ddI)
Viracept (nelfinavir)
Viral Load (HIV RNA or HIV bDNA)
Viramune (nevirapine)
Viread (tenofovir)
Virologic Control
Virologic Failure
W
Wasting - HIV
Women
Z
Zerit (stavudine; d4T)
Ziagen (abacavir)